Description
COMPOSITION: Each tablet contains sofosbuvir 400 mg + velpatasavir 100 mg
INDICATION: VELAKAST is Indicated for the treatment of chronic HcV genotypes 1-6 in adults:
- without cirrhosis or with compensated cirrhosis (child-Pugh A)
- with decompensated cirrhosis (child-Pugh B and c) combined with ribavirin
PACKING: 28 Tablets / Bottle